scholarly journals Compression therapy in venous diseases: physical assumptions and clinical effects

2019 ◽  
Author(s):  
Andrzej Berszakiewicz ◽  
Aleksander Sieroń ◽  
Zbigniew Krasiński ◽  
Armand Cholewka ◽  
Agata Stanek
Keyword(s):  
Compression Therapy ◽  
Clinical Effects ◽  
Venous Diseases

scholarly journals Contribution of textile technology to the development of modern compression bandages

2007 ◽  
Vol 13 (2) ◽  
pp. 88-102 ◽  
Author(s):  
Svetlana Milosavljevic ◽  
Petar Skundric
Keyword(s):  
Compression Therapy ◽  
Lower Limbs ◽  
Venous Disease ◽  
Clinical Effects ◽  
Textile Materials ◽  
Compression Bandages ◽  
Venous Diseases ◽  
Textile Technology ◽  
Key Factor ◽  
Application Techniques

Although compression therapy is a key factor in the successful treatment of some circulatory problems in lower limbs, this form of therapy includes some risks if used inappropriately. Based on deliberate application of pressure to a lower limb, using a variety of textile materials, elastic or rigid, in order to produce a desired clinical effects, modern compression therapy presents a good sample of successful penetration of textile technology into the phlebology field of medicine. However, although compression therapy has been in use for over 150 years, there exists a low awareness among practitioners and patients on product usage, application techniques and benefits of appropriate selection of bandages for determined types of leg venous diseases. Also, not all manufacturers of compression textile materials seem to be conscious of end - users' needs. Simultaneously, impressive developments in the field of elastan fibers and modern knitting and weaving technologies, offer chances for realization of completely new types of compression bandages, capable of making an important contribution to the management of venous disease. In this review, starting from the brief account of pathogenesis and the presentation of compression therapy principle, an account of the contribution of all sectors in the textile technological chain to a modern compression therapy is given.

I) Introduction

VASA ◽  
2003 ◽  
Vol 32 (Supplement 63) ◽  
pp. 3-6
Keyword(s):  
Randomized Controlled Trials ◽  
Current Practice ◽  
Compression Therapy ◽  
Controlled Trials ◽  
Clinical Effects ◽  
Randomized Controlled ◽  
Venous Diseases ◽  
Based Medicine ◽  
Near Future ◽  
Venous Disorders

Background. The use of compression therapy is mainly based on tradition and experience. Randomized controlled trials demonstrating clinical effects in different indications are rare or non-existing. A clear proof of effectiveness for different compression devices endorsed by evidence based medicine will be a prerequisite for reimbursement by health budgets in the near future. Against this background a group of experts has discussed and approved the following position document under the auspices of the International Union of Phlebology. Indications for compression therapy in phlebology and lymphology are mainly: 1. Chronic venous disorders (CEAP C0-C6 ) (1) 2. Acute venous diseases 3. Lymphoedema. The following 3 questions are discussed for every single indication: ¥ What is done? (Current practice and rationale) ¥ What do we know? (Level of recommendation based on present knowledge) ¥ What do we need to know? (Proposals for randomized controlled trials on compression therapy)

scholarly journals Long-term compression therapy in patients with chronic venous diseases - fantasy and realityIntroduction

2018 ◽  
Vol 20 (2) ◽  
pp. 93-95
Author(s):  
Leo Puszkailer ◽  
Jan Bialek ◽  
Dalibor Musil ◽  
Kateřina Langová
Keyword(s):  
Compression Therapy ◽  
Venous Diseases

scholarly journals THE APPLICATION OF COMPRESSION THERAPY IN PATIENTS WITH VARICOSE VEINS OF THE LOWER EXTREMITIES

2021 ◽  
Vol 29 (3) ◽  
pp. 302-310
Author(s):  
I.M. Ihnatovich ◽  
◽  
D.M. Bontsevich ◽  
B.A. Maslianski ◽  
Yu.S. Nebylitsyn ◽  
...  
Keyword(s):  
Call Center ◽  
Telephone Survey ◽  
Varicose Veins ◽  
Lower Extremities ◽  
Compression Therapy ◽  
Registration Data ◽  
Venous Diseases ◽  
History Of ◽  
Prospective Comparative Study ◽  
Medical Recommendations

Objective. To study the implementation of medical recommendations regarding the use of compression therapy in patients with varicose veins of the lower extremities. Methods. A prospective comparative study, Patients Commitment to Compression Therapy (POMP), was conducted with the participation of phlebologist-surgeons who treat patients with chronic venous diseases in Minsk, Vitebsk, and Gomel. During 5 weeks each of the phlebologists included in the study patients with varicose veins who sought advice and needed compression therapy. 30-35 days after the consultation of the surgeon-phlebologist, an outsourcing call center conducted a telephone survey of patients in order to obtain information about the specifics of fulfilling medical recommendations. Results. The registration data base of the study contained individual data on 394 patients with varicose veins (C1-C6) who received recommendations to use compression therapy. After 30-35 days, 302 patients (aged 43, 18-84 (Me, IQR)) were available for telephone survey. There were 58 men (19.2%), 244 women (80.8%). Among them, class C1 was registered in 39 (12.9%), C2 - in 113 (37.4%), C3 - in 122 (40.4%), C4 - in 25 (8.3%), C5 - in 1 (0.3%), C6 - in 2 (0.7%) patients. It was found that 245 (81.5%) of the respondents either already had compression hosiery at the time of the consultation, or purchased it within 30 days. 228 (75.2%) respondents reported compliance with the recommendations. Patients who had already experience with compression therapy and patients with the history of venous thromboembolism showed higher commitment to compression therapy (p<0.001). There were no significant differences in the compliance of patients with different levels of education and professional characteristics. Conclusion. A high commitment of patients to compression therapy was established 1 month after receiving recommendations. To obtain more information about patient compliance, it is necessary to enlarge the follow-up period. What this paper adds In a prospective multicenter study a high commitment (75.2%) to compression therapy for patients with varicose veins was firstly defined 1 month after the recommendations made by a phlebologist to use it.

scholarly journals Safety of medical compression stockings in patients with diabetes mellitus or peripheral arterial disease

2020 ◽  
Vol 8 (1) ◽  
pp. e001316
Author(s):  
Ulrich Rother ◽  
Anna Grussler ◽  
Colin Griesbach ◽  
Veronika Almasi-Sperling ◽  
Werner Lang ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Peripheral Arterial Disease ◽  
Compression Therapy ◽  
Arterial Disease ◽  
Compression Stockings ◽  
Doppler Flowmetry ◽  
Venous Diseases ◽  
Patients With Diabetes ◽  
Peripheral Arterial ◽  
Medical Compression Stockings

IntroductionCompression therapy is highly effective in the treatment of many venous diseases, including leg edema. However, its relevance in patients with peripheral arterial disease (PAD) or diabetes mellitus is critically discussed. The aim of the present study was to assess the influence of compression therapy on microperfusion and its safety in patients with PAD or diabetes mellitus.Research design and methodsA prospective analysis of 94 consecutive patients (44 patients with diabetes, 45 patients with PAD and 5 healthy controls) undergoing medical compression therapy was performed. Microperfusion was assessed by a combined method of white light tissue spectrometry and laser Doppler flowmetry under medical compression therapy (classes I and II), in different body positions (supine, sitting, standing and elevated position of the leg) and at different locations (great toe, lateral ankle and calf).ResultsDuring the entire study, no compression-related adverse events occurred. Evaluation of microcirculation parameters (oxygen saturation of hemoglobin and flow) at the different locations and in sitting and standing positions (patients with diabetes and PAD) under compression therapy classes I and II revealed no tendency for reduced microperfusion in both groups. In contrast, in the elevated leg position, all mean perfusion values decreased in the PAD and diabetes groups. However, the same effect was seen in the healthy subgroup.ConclusionsIn consideration of the present inclusion criteria, use of medical compression stockings is safe and feasible in patients with diabetes or PAD. This study did not find relevant impairment of microperfusion parameters under compression therapy in these patient subgroups in physiologic body positions.Trial registration numberNCT03384758.

scholarly journals Comparison of Intermittent Pneumatic Compression Device and Compression Stockings for Workers with Leg Edema and Pain after Prolonged Standing

2021 ◽  
Author(s):  
Da-Sol Kim ◽  
Yu Hui Won ◽  
Myoung-Hwan Ko
Keyword(s):  
Compression Therapy ◽  
Intermittent Pneumatic Compression ◽  
Leg Pain ◽  
Venous Stasis ◽  
Venous Disease ◽  
Compression Stockings ◽  
Prolonged Standing ◽  
Venous Diseases ◽  
Leg Edema ◽  
Total Body

During prolonged standing, insufficient calf muscle pumping accompanies venous stasis and hypertension in the lower legs, resulting in valve dysfunction, venous wall problems, and subsequent inflammation. Compression therapy, which includes medical compression stockings (MCS) and mechanical intermittent pneumatic compression (IPC), is one of the most effective therapeutic interventions for treating chronic venous diseases. This study aimed to investigate the safety and efficacy of IPC and MCS, and the optimal protocol of compression therapy for chronic venous disease. This crossover trial was conducted for healthy, long standing workers (&gt;8 h daily) with leg edema and pain. Four groups were established for each visit: group A (resting after work without MCS), group B (resting after work with MCS), group C (IPC after work without MCS), and group D (IPC after work with MCS). The primary outcome was the visual analogue scale (VAS) score for leg pain. The secondary outcomes were leg volume (mL), circumference (cm), extracellular fluid/total body fluid (ECF/TBF), and extracellular water/total body water (ECW/TBW) through bioimpedance analysis. Outcomes were assessed before work (T0), after work (T1), and 60 minutes after intervention (T2). We included 39 healthy volunteers, aged 30.03&plusmn;7.56 years. All four groups had significantly increased leg pain after work (T0-1) but improved 60 minutes after intervention (T1-2), particularly group C (decreased VAS by 1.9). When leg swelling was compared at T0 and T1, groups A and C showed significant increases in leg volume and circumference, indicating significant work-induced edema, whereas groups B and D showed no change or even a decrease. After interventions, leg volume and circumference significantly decreased in groups A and C, although groups B and C did not show significant improvement. The ECF/TBF and ECW/TBW of all groups decreased after interventions. Leg pain and edema after prolonged standing in healthy adults were safely and effectively improved by IPC. Although MCS also reduced leg edema immediately after work, it did not show significant improvement in leg pain at T0-1&ndash;and T1-2, nor in swelling at T1-2.

scholarly journals Compression therapy in venous diseases: current forms of compression materials and techniques

2019 ◽  
Author(s):  
Andrzej Berszakiewicz ◽  
Aleksander Sieroń ◽  
Zbigniew Krasiński ◽  
Armand Cholewka ◽  
Agata Stanek
Keyword(s):  
Compression Therapy ◽  
Venous Diseases

scholarly journals Clinical guidelines for sclerotherapy: implementation in actual practice

2021 ◽  
pp. 27-35
Author(s):  
S. M. Markin ◽  
V. Yu. Bogachev ◽  
S. V. Grishin ◽  
P. F. Kravtsov ◽  
K. V. Mazayshvili
Keyword(s):  
High Efficiency ◽  
Varicose Veins ◽  
Low Cost ◽  
Professional Community ◽  
Compression Therapy ◽  
Significant Heterogeneity ◽  
Outpatient Basis ◽  
Clear Cut ◽  
Regulatory Documents ◽  
Venous Diseases

Introduction. The simplicity of the sclerotherapy procedure, its high efficiency and low cost along with the possibility of performing the procedure on an outpatient basis stimulate the widespread use of the method.Objective of the study. Examine the current state of actual clinical practice regarding the treatment of patients with varicose veins using the sclerotherapy procedure.Materials and methods. An anonymous survey of 162 doctors, members of the professional community of specialists engaged in the treatment of venous diseases was performed. It comprised 15 questions concerning the features of the sclerotherapy procedure and following up of the patients.Results and discussion. The lack of clear-cut standardization for sclerotherapy in the regulatory documents contributes to the significant heterogeneity in the approaches of specialists to the performance of the procedure. The views on the use of sclerotherapy to remove perineal varicose veins (routinely performed only by 25.3% of physicians) and the upper extremity veins (less than 4%) turned out to be controversial. There were significant differences in the therapeutic approaches to the administration of anticoagulants by the patients (refusal in the procedure – 26.3% of respondents, discontinuation of drugs during sclerotherapy – 7.5%). Approximately a third of the respondents regularly exceed recommended 10 ml-volume of foam per session, there is no consensus on the choice of the needle diameter, drug concentration even in the similar clinical situations. About half of them have experience in using glucose as the sclerosant, every third – in using a transcutaneous laser, 5.6% – in using the mechanochemical obliteration techniques that are not currently certified in the Russian Federation. The use of compression therapy after sclerotherapy is not standardized; the regulatory documents provide contradictory durations of its use, which is due to the weakness of clinical research data on this issue. Up to 99% of physicians observe pigmentation, 83.2% – development of secondary telangiectasias and 60.2% – superficial necrosis in their practice. These circumstances arouse legal suspicion in relation to this type of treatment and the legal vulnerability of physicians. At the same time, physicians need to be more informed about the current requirements for some issues.Conclusion. The current legislation regulating the practical aspects of the sclerotherapy considers it largely through the lens of medicine, ignoring a significant cosmetic component. It is necessary to work out the provisions describing the specifics of cosmetic manipulations performed by the phlebologists, and the need for more detailed familiarization with the regular updates of the guidelines.

Medetomidine and atipamezole in sheep: disposition and clinical effects

2000 ◽  
Vol 23 (6) ◽  
pp. 401-404 ◽  
Author(s):  
B. RANHEIM ◽  
J. M. ARNEMO ◽  
S. STUEN ◽  
T. E. HORSBERG
Keyword(s):  
Clinical Effects
Sign in / Sign up

Export Citation Format

Share Document